Episode
Ensign Group Stock: The Quiet Skilled-Nursing Compounder Beat AND Raised — Our BUY Call (ENSG)
- Published
- Jul 27, 2026
- Duration seconds
- 842
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/charged-alpha-stock-encyclopedia-7819792/episodes/ensign-group-stock-the-quiet-skilled-nursing-compounder-beat-and-raised-our-buy-call-ensg/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/charged-alpha-stock-encyclopedia-7819792/ensign-group-stock-the-quiet-skilled-nursing-compounder-beat-and-raised-our-buy-call-ensg.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
The Ensign Group (ENSG) Q2 2026 — The Ensign Group (ENSG), a decentralized operator of skilled-nursing and post-acute facilities plus its captive real-estate arm Standard Bearer, reported Q2 2026 (quarter ended June 30, 2026): adjusted diluted EPS of $1.92 beat the ~$1.80 consensus and rose 20.8% YoY, with GAAP diluted EPS of $1.68 (+16.7%). Revenue grew 17.3% to $1.44B (from $1.23B). Same-facility occupancy climbed to 84.1% (+2.7 pts) and transitioning-facility occupancy to 84.7%, while skilled-mix days rose 6.2% (same-facility) and 9.4% (transitioning) and managed-care revenue jumped up to 16.2% — the occupancy-plus-mix combination that drives margins. Standard Bearer rental revenue grew 40.2% to $44.1M with FFO up 34.6% to $24.7M; Ensign now owns 183 real-estate assets and runs 398 operations across 17 states, having added 20 new operations (all with real estate) in the quarter and 102 since 2024. Management RAISED FY2026 guidance again — adjusted EPS to $7.75-$7.85 (from $7.48-$7.62) and revenue to $5.87-$5.92B — the midpoint +18.7% over 2025 and +41.8% over 2024. Liquidity is $262.3M cash + $591.6M revolver; net debt ~3x EBITDA; Q2 free cash flow $119M. The stock (~$173, +3.3% on the print) is ~21% off its $218 high after a 25% drawdown to $142. Our owner-earnings DCF (base +13% decel, 9% discount) lands fair value ~$205 — roughly 19% upside. Our call: BUY, 4/5. The Street also rates it Buy (~$218 avg target, 9 buys / 2 holds / 2 sells), so we're ALIGNED on the verdict, a touch more conservative on the target. The Ensign Group (ENSG) is one of the quietest compounders in healthcare — a decentralized operator of skilled-nursing and senior-living facilities that pushes decision-making down to local leaders, buys underperforming facilities cheap, fixes them, and comp…